Products for Research Use Only
RegisterLogin

Visilizumab

CAT: 0804-HY-P99332-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99332-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Visilizumab (Anti-Human CD3E Recombinant Antibody) is a humanized low-Fc receptor binding anti-CD3 monoclonal IgG2 antibody. Visilizumab can be used for ulcerative colitis and Crohn's disease research[1].
CAS Number
219716-33-3
Product Name Alternative
Anti-Human CD3E Recombinant Antibody; HuM291
UNSPSC
12352203
Target
Apoptosis
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/visilizumab.html
Purity
99.49
Solubility
10 mM in DMSO
Smiles
[Volociximab]
Molecular Weight
(144.66 kDa)
References & Citations
[1]Qi T Yu, et al. Visilizumab induces apoptosis of mucosal T lymphocytes in ulcerative colitis through activation of caspase 3 and 8 dependent pathways. Clin Immunol. 2008 Jun;127 (3) :322-9.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
T76839-01Visilizumab
GTR18337940-01Visilizumab Antibody
592304Visilizumab (CD3E)
047888CD3 (visilizumab) discontinued
A2816-1mgVisilizumab (Anti-CD3)
HY057046-01Research Grade Visilizumab
E55B0300Visilizumab (Reference antibody)
ICH5982-25mgVisilizumab Biosimilar - Research Grade
F1054-5Anti-CD3 Antibody (Visilizumab)
GTR18315649CD3 Reference Antibody (visilizumab)

Popular Products